Currently Only Enrolling Glioblastoma Patients at First Recurrence

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Currently Only Enrolling Glioblastoma Patients at First Recurrence trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

SuspendedPhase 1

NCT05139056

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-…

This phase I trial studies the safety of giving multiple intracerebral doses of NSC-CRAd-S-pk7 to treat patients with glioblastoma at first recurrence. NSC-CRAd…

United States36 participantsStarted 2023-05-02

Treatment: Neural Stem Cells-expressing CRAd-S-pk7, Resection